Skip to main content
SpringerLink
Log in

Appraisal of Hepatic Resection in the Treatment of Hepatocellular Carcinoma with Severe Thrombocytopenia

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Hepatic resection for hepatocellular carcinoma (HCC) patients with liver cirrhosis and severe hypersplenic thrombocytopenia is risky and controversial.

Methods

From 1989 to 2005, 341 patients underwent hepatic resection for HCC in our hospital. Of these, 15 patients were concomitant with severe thrombocytopenia (platelet count, ≤5 × 104/mm3), and their clinical outcomes were retrospectively reviewed.

Results

Among the 15 patients, 11 underwent hepatectomy alone and 4 underwent concomitant splenectomy. The mean preoperative platelet count was 4.2 ± 0.8 × 104/mm3 (range, 1.9–5 x 104/mm3). The surgical procedures performed were partial resection in five patients, subsegmentectomy in three, and segmentectomy in seven. A blood transfusion was required for 11 of 15 patients, and 8 of these received a platelet-rich plasma transfusion. With the exception of one patient who suffered from postoperative liver failure, all the patients had an uneventful postoperative course. The 3-year cumulative survival rate of these patients was comparable to those without thrombocytopenia.

Conclusions

Severe thrombocytopenia alone is not a contraindication for hepatectomy in patients with HCC associated with liver cirrhosis. For these patients, hepatic resection—hepatectomy alone or concomitant splenectomy—should be considered as a treatment option.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Okita K (2006) Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 45:229–233

    Article  PubMed  Google Scholar 

  2. Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235

    Article  PubMed  Google Scholar 

  3. Belghiti J, Ogata S (2005) Assessment of hepatic reserve for the indication of hepatic resection. J Hepatobiliary Pancreat Surg 12:1–3

    Article  PubMed  Google Scholar 

  4. Paquet KJ (2001) Surgery for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Surg Endosc 15:104–105

    Article  PubMed  CAS  Google Scholar 

  5. Marin-Hargreaves G, Azoulay D, Bismuth H (2003) Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 47:13–27

    Article  PubMed  Google Scholar 

  6. Yanaga K (2004) Current status of hepatic resection for hepatocellular carcinoma. J Gastroenterol 39:919–926

    Article  PubMed  Google Scholar 

  7. Makuuchi M, Sano K (2004) The surgical approach to HCC: our progress and results in Japan. Liver Transpl 10(2 Suppl 1):S46–S52

    Article  PubMed  Google Scholar 

  8. Liver Cancer Study Group of Japan (2001) The general rules for the clinical and pathological study of primary liver cancer, 4th edn. Kanehara, Tokyo

    Google Scholar 

  9. Imamura H, Sano K, Sugawara Y et al (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12:16–22

    Article  PubMed  Google Scholar 

  10. Poon RT, Fan ST, Lo CM et al (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698–710

    Article  PubMed  Google Scholar 

  11. Wu CC, Cheng SB, Ho WM et al (2004) Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery 136:660–668

    Article  PubMed  Google Scholar 

  12. Sugawara Y, Yamamoto J, Shimada K et al (2000) Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 190:446–450

    Article  PubMed  CAS  Google Scholar 

  13. Cao ZX, Chen XP, Wu ZD (2003) Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma. World J Gastroenterol 9:2460–2463

    PubMed  Google Scholar 

  14. Oh JW, Ahn SM, Kim KS et al (2003) The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism. Yonsei Med J 44:1053–1058

    PubMed  Google Scholar 

  15. Shimada M, Hashizume M, Shirabe K et al (2000) A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc 14:127–130

    PubMed  CAS  Google Scholar 

  16. Sangro B, Bilbao I, Herrero I et al (1993) Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18:309–314

    Article  PubMed  CAS  Google Scholar 

  17. Ikai I, Arii S, Ichida T et al (2005) Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 32:163–172

    Article  PubMed  Google Scholar 

  18. Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796–802

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Fukuoka City Hospital, 13-1 Yoshizuka-honmachi, Hakata-ku, Fukuoka, 812-0046, Japan

    Keishi Sugimachi, Yasuharu Ikeda, Morimasa Tomikawa, Shuichi Tsukamoto, Katsumi Kawasaki, Shinji Yamamura, Daisuke Korenaga & Kenji Takenaka

  2. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Keishi Sugimachi, Akinobu Taketomi & Yoshihiko Maehara

Authors
  1. Keishi Sugimachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuharu Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Morimasa Tomikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akinobu Taketomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuichi Tsukamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Katsumi Kawasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shinji Yamamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Daisuke Korenaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoshihiko Maehara
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kenji Takenaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keishi Sugimachi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugimachi, K., Ikeda, Y., Tomikawa, M. et al. Appraisal of Hepatic Resection in the Treatment of Hepatocellular Carcinoma with Severe Thrombocytopenia. World J Surg 32, 1077–1081 (2008). https://doi.org/10.1007/s00268-007-9442-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-007-9442-3

Keywords

Search

Navigation